1、 YANG M J, LEE H C, LEE H W, et al. Effect of nicorandil on clinical outcomes in patients with ST-segment elevation and non-ST-segment elevation myocardial infarction: based on the Korea Acute Myocardial Infarction Registry (KAMIR)[J]. Int J Cardiol,2013,168(5):4868-4869. YANG M J, LEE H C, LEE H W, et al. Effect of nicorandil on clinical outcomes in patients with ST-segment elevation and non-ST-segment elevation myocardial infarction: based on the Korea Acute Myocardial Infarction Registry (KAMIR)[J]. Int J Cardiol,2013,168(5):4868-4869.
2、 ISHII H, ICHIMIYA S, KANASHIRO M, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction[J]. Circulation, 2005,112(9):1284-1288. ISHII H, ICHIMIYA S, KANASHIRO M, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction[J]. Circulation, 2005,112(9):1284-1288.
3、 ITO N, NANTO S, DOI Y, et al. High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intracoronary administration of nicorandil[J]. Circ J, 2010,74(5):909-915. ITO N, NANTO S, DOI Y, et al. High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intracoronary administration of nicorandil[J]. Circ J, 2010,74(5):909-915.
4、 LEE H L, CHANG P C, CHOU C C, et al. Blunted proarrhythmic effect of nicorandil in a Langendorff-perfused phase-2 myocardial infarction rabbit model[J]. Pacing Clin Electrophysiol, 2013,36(2):142-151. LEE H L, CHANG P C, CHOU C C, et al. Blunted proarrhythmic effect of nicorandil in a Langendorff-perfused phase-2 myocardial infarction rabbit model[J]. Pacing Clin Electrophysiol, 2013,36(2):142-151.
5、 WU M, HUANG Z, XIE H, ZHOU Z. Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis[J]. PloS One, 2013,8(10):e78231. WU M, HUANG Z, XIE H, ZHOU Z. Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis[J]. PloS One, 2013,8(10):e78231.
6、 HWANG J, LEE H C, KIM B W, et al. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina[J]. Int J Cardiol, 2013,62(2):77-81. HWANG J, LEE H C, KIM B W, et al. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina[J]. Int J Cardiol, 2013,62(2):77-81.
7、 KIM S J, KIM W, WOO J S, et al. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial[J]. Int J Cardiol, 2012,158(1):88-92. KIM S J, KIM W, WOO J S, et al. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial[J]. Int J Cardiol, 2012,158(1):88-92.
8、 KOSTIC J, DJORDJEVIC-DIKIC A, DOBRIC M, et al. The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI[J]. Cardiovasc Ultrasound,2015(13):26. KOSTIC J, DJORDJEVIC-DIKIC A, DOBRIC M, et al. The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI[J]. Cardiovasc Ultrasound,2015(13):26.
9、 YANG J, ZHANG J, CUI W, et al. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention[J]. Anadolu Kardiyol Derg,2015,15(2):125-131. YANG J, ZHANG J, CUI W, et al. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention[J]. Anadolu Kardiyol Derg,2015,15(2):125-131.
10、 YAMADA K, ISOBE S, ISHII H, et al. Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging[J]. Heart and vessels,2016,31(9):1430-1437. YAMADA K, ISOBE S, ISHII H, et al. Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging[J]. Heart and vessels,2016,31(9):1430-1437.
11、 WANG Y Y, LI T, LIU Y W, et al. Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention[J]. Zhonghua Xin Xue Guan Bing Za Zhi, 2017, 45(4): 277-282. WANG Y Y, LI T, LIU Y W, et al. Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention[J]. Zhonghua Xin Xue Guan Bing Za Zhi, 2017, 45(4): 277-282.
12、 PANG Z, ZHAO W, YAO Z. Cardioprotective effects of nicorandil on coronary heart disease patients undergoing elective percutaneous coronary intervention [J]. Med Sci Monit, 2017, 15(23):2924-2930. PANG Z, ZHAO W, YAO Z. Cardioprotective effects of nicorandil on coronary heart disease patients undergoing elective percutaneous coronary intervention [J]. Med Sci Monit, 2017, 15(23):2924-2930.
13、 ZHAO Z Q, CORVERA J S, HALKOS M E, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning[J]. Am J Physiol Heart Circ Physiol, 2003,285(2):H579-588. ZHAO Z Q, CORVERA J S, HALKOS M E, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning[J]. Am J Physiol Heart Circ Physiol, 2003,285(2):H579-588.
14、 MURRY CE, JENNINGS RB, REIMER KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium[J]. Circulation,1986,74(5):1124-1136. MURRY CE, JENNINGS RB, REIMER KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium[J]. Circulation,1986,74(5):1124-1136.
15、 RODRIGUEZ-PASCUAL F, BUSNADIEGO O, LAGARES D, et al. Role of endothelin in the cardiovascular system[J]. Pharmacol Res,2011,63(6):463-472. RODRIGUEZ-PASCUAL F, BUSNADIEGO O, LAGARES D, et al. Role of endothelin in the cardiovascular system[J]. Pharmacol Res,2011,63(6):463-472.
16、 KIKUCHI Y, YASUDA S, AIZAWA K, et al. Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment[J]. J Am Coll Cardiol, 2011,58(12):1231-1237. KIKUCHI Y, YASUDA S, AIZAWA K, et al. Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment[J]. J Am Coll Cardiol, 2011,58(12):1231-1237.
17、 SMITH K J, CHADBURN A J, ADOMAVICIENE A, et al. Coronary spasm and acute myocardial infarction due to a mutation (V734I) in the nucleotide binding domain 1 of ABCC9[J]. Int J Cardiol, 2013,168(4):3506-3513. SMITH K J, CHADBURN A J, ADOMAVICIENE A, et al. Coronary spasm and acute myocardial infarction due to a mutation (V734I) in the nucleotide binding domain 1 of ABCC9[J]. Int J Cardiol, 2013,168(4):3506-3513.
18、 LI W, WU N, SHU W, et al. Pharmacological preconditioning and postconditioning with nicorandil attenuates ischemia/reperfusion-induced myocardial necrosis and apoptosis in hypercholesterolemic rats [J]. Exp Ther Med, 2015, 10(6): 2197-2205. LI W, WU N, SHU W, et al. Pharmacological preconditioning and postconditioning with nicorandil attenuates ischemia/reperfusion-induced myocardial necrosis and apoptosis in hypercholesterolemic rats [J]. Exp Ther Med, 2015, 10(6): 2197-2205.
19、 WU H, YE M, YANG J, et al. Nicorandil protects the heart from ischemia/reperfusion injury by attenuating endoplasmic reticulum response-induced apoptosis through pi3k/akt signaling pathway[J]. Cell Physiol Biochem, 2015,35(6):2320-2332. WU H, YE M, YANG J, et al. Nicorandil protects the heart from ischemia/reperfusion injury by attenuating endoplasmic reticulum response-induced apoptosis through pi3k/akt signaling pathway[J]. Cell Physiol Biochem, 2015,35(6):2320-2332.
20、 RAVINDRAN S, MURALI J, AMIRTHALINGAM S K, et al. Vascular calcification abrogates the nicorandil mediated cardio-protection in ischemia reperfusion injury of rat heart [J]. Vascul Pharmacol, 2017(89):31-38. RAVINDRAN S, MURALI J, AMIRTHALINGAM S K, et al. Vascular calcification abrogates the nicorandil mediated cardio-protection in ischemia reperfusion injury of rat heart [J]. Vascul Pharmacol, 2017(89):31-38.
21、 CHEN Z, CHEN X, LI S, et al. Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow[J]. Coron Artery Dis,2015,26(2):114-120. CHEN Z, CHEN X, LI S, et al. Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow[J]. Coron Artery Dis,2015,26(2):114-120.
22、 ZALEWSKI J, NESSLER J. The endogenous cardioprotection during reperfusion in acute myocardial infarction [J]. Kardiologia Polska, 2011,69 Suppl(3):67-74. ZALEWSKI J, NESSLER J. The endogenous cardioprotection during reperfusion in acute myocardial infarction [J]. Kardiologia Polska, 2011,69 Suppl(3):67-74.
23、 ASENSIO-LóPEZ M C, SOLER F, PASCUAL-FIGAL D, et al. Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes [J]. PloS One, 2017, 12(2): e0172803. ASENSIO-LóPEZ M C, SOLER F, PASCUAL-FIGAL D, et al. Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes [J]. PloS One, 2017, 12(2): e0172803.
24、 AMBROSIO G, KOMAJDA M, MUGELLI A, et al. Management of stable angina: A commentary on the European Society of Cardiology guidelines [J]. Eur J Prev Cardiolog, 2016, 23(13): 1401-1412. AMBROSIO G, KOMAJDA M, MUGELLI A, et al. Management of stable angina: A commentary on the European Society of Cardiology guidelines [J]. Eur J Prev Cardiolog, 2016, 23(13): 1401-1412.
25、 THE IONA STUDY GROUP.Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil in Angina (IONA) randomised trial[J]. Lancet, 2002,359(9314):1269-1275. THE IONA STUDY GROUP.Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil in Angina (IONA) randomised trial[J]. Lancet, 2002,359(9314):1269-1275.
26、 WANG Z Q, CHEN M X, LIU D L, et al. The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction [J]. Zhonghua Xin Xue Guan Bing Za Zhi, 2017, 45(1): 26-33. WANG Z Q, CHEN M X, LIU D L, et al. The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction [J]. Zhonghua Xin Xue Guan Bing Za Zhi, 2017, 45(1): 26-33.
27、 YANG J, ZHANG J, CUI W, et al. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention [J]. Anadolu Kardiyol Derg, 2015, 15(2): 125-31. YANG J, ZHANG J, CUI W, et al. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention [J]. Anadolu Kardiyol Derg, 2015, 15(2): 125-31.
